Pfizer Inc.

PFE | NYSE

Price Alert Chart Builder DCF Calculator

$27.74

+$0.08 (+0.29%)

At close: Sep 21, 2026, 4:02 PM ET

$27.70

-$0.04 (-0.14%)

Pre-market: Sep 22, 2026, 5:12 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 27, 2026	Q1 2026 Mar 28, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 27, 2025	Q2 2025 Jun 28, 2025	Q1 2025 Mar 29, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 28, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 30, 2023	Q2 2023 Jul 1, 2023	Q1 2023 Apr 1, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Oct 1, 2022	Q2 2022 Jul 2, 2022	Q1 2022 Apr 2, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Oct 2, 2021	Q2 2021 Jul 3, 2021	Q1 2021 Apr 3, 2021
Revenue	15.03B	14.45B	17.56B	16.65B	14.65B	13.72B	17.76B	17.7B	13.28B	14.88B	14.57B	13.49B	13.01B	18.49B	24.29B	22.64B	27.74B	25.66B	23.84B	24.04B	18.9B	14.52B
Cost of Revenue	4.09B	4.73B	5.27B	4.17B	5.23B	3.89B	4.8B	6.93B	5.04B	4.38B	8.59B	10.6B	4.6B	5.95B	10.9B	6.99B	9.07B	10.8B	10.68B	10.86B	7.85B	5B
Gross Profit	10.94B	9.72B	12.29B	12.48B	9.42B	9.83B	12.97B	10.77B	8.24B	10.5B	5.98B	2.89B	8.41B	12.54B	13.39B	15.65B	18.68B	14.86B	13.16B	13.18B	11.05B	9.52B
Operating Income	4.71B	4.03B	3.69B	3.55B	3.58B	4.62B	5.73B	4.97B	1.88B	4.56B	-1.26B	-3.01B	2.35B	6.69B	5.35B	9.7B	12.95B	10.04B	3.28B	7.75B	5.99B	4.81B
Interest Income	113M	115M	166M	138M	156M	143M	170M	116M	130M	129M	609M	523M	316M	177M	137M	70M	30M	14M	14M	10M	13M	n/a
Pretax Income	-653M	3.17B	-1.64B	3.33B	3.04B	2.78B	-10M	4.72B	-103M	3.42B	-4.13B	-3.35B	2.27B	6.27B	5.23B	9B	11.45B	9.05B	3.83B	7.84B	6.95B	5.69B
Net Income	-246M	2.69B	-1.65B	3.54B	2.91B	2.97B	403M	4.47B	24M	3.12B	-3.34B	-2.39B	2.33B	5.54B	4.99B	8.63B	9.87B	7.87B	3.39B	8.16B	5.8B	4.88B
Selling & General & Admin	3.41B	2.96B	3.73B	3.19B	3.4B	3.02B	4.23B	3.24B	3.69B	3.46B	4.47B	3.21B	3.43B	3.36B	4.43B	3.25B	2.91B	2.52B	3.97B	2.75B	2.83B	2.71B
Research & Development	2.81B	2.63B	3.42B	3.94B	2.44B	2.18B	3.02B	2.57B	2.68B	2.48B	2.77B	2.68B	2.63B	2.49B	3.62B	2.7B	2.82B	2.3B	5.92B	2.68B	2.24B	1.99B
Other Expenses	16M	100M	1.45B	1.81B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	6.24B	5.69B	8.6B	8.93B	5.85B	5.2B	7.24B	5.8B	6.36B	5.94B	7.24B	5.89B	6.06B	5.85B	8.04B	5.95B	5.73B	4.82B	9.88B	5.43B	5.07B	4.71B
Interest Expense	667M	668M	711M	652M	654M	654M	739M	783M	778M	790M	689M	695M	508M	318M	313M	311M	293M	322M	315M	325M	316M	336M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	10.33B	10.42B	13.87B	13.1B	11.08B	9.09B	12.04B	12.73B	11.4B	10.32B	15.83B	16.5B	10.66B	11.8B	18.94B	12.94B	14.8B	15.62B	20.56B	16.29B	12.91B	9.71B
Income Tax Expense	-407M	461M	-2M	-216M	141M	-189M	-421M	234M	-134M	293M	-794M	-964M	-71M	715M	230M	356M	1.57B	1.17B	249M	-328M	1.12B	808M
Shares Outstanding (Basic)	5.7B	5.69B	5.68B	5.69B	5.69B	5.68B	5.67B	5.67B	5.67B	5.66B	5.65B	5.65B	5.65B	5.63B	5.62B	5.61B	5.59B	5.62B	5.62B	5.61B	5.6B	5.58B
Shares Outstanding (Diluted)	5.7B	5.73B	5.69B	5.71B	5.71B	5.71B	5.7B	5.71B	5.7B	5.7B	5.65B	5.65B	5.71B	5.73B	5.74B	5.72B	5.71B	5.76B	5.77B	5.73B	5.68B	5.66B
EPS (Basic)	-0.04	0.47	-0.29	0.62	0.51	0.52	0.07	0.79	0	0.55	-0.60	-0.42	0.41	0.98	0.89	1.54	1.77	1.40	0.60	1.45	1.04	0.87
EPS (Diluted)	-0.04	0.47	-0.29	0.62	0.51	0.52	0.07	0.78	0	0.55	-0.60	-0.42	0.41	0.97	0.87	1.51	1.73	1.37	0.59	1.43	1.02	0.86
EBITDA	1.2B	5.02B	756M	5.65B	5.32B	5.06B	5.14B	7.25B	2.41B	5.95B	-1.77B	-1.1B	4.35B	8.08B	7.06B	10.5B	12.91B	10.56B	5.42B	9.51B	8.57B	7.24B
EBIT	14M	3.84B	-931M	3.99B	3.7B	3.44B	3.35B	5.5B	674M	4.21B	-3.44B	-2.66B	2.78B	6.59B	5.55B	9.31B	11.74B	9.37B	4.14B	8.17B	7.26B	6.03B
Depreciation & Amortization	1.19B	1.18B	1.69B	1.66B	1.63B	1.62B	1.79B	1.76B	1.73B	1.74B	1.67B	1.56B	1.57B	1.49B	1.52B	1.18B	1.18B	1.19B	1.28B	1.34B	1.31B	1.21B